{"meta":{"query_hash":"a36e830bb1f5","filters":{"venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a36e830bb1f5","api":"https://metacan.xera.ac/api/v1/cohort?venue=Applied+Clinical+Research+Clinical+Trials+and+Regulatory+Affairs"},"results":[{"id":"W2757851334","doi":"10.2174/2213476x03666160112001136","title":"Product Life Cycle Management for Pharmaceutical Innovation","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scrutiny; Commercialization; Product lifecycle; Business; Product (mathematics); New product development; Scope (computer science); Biosimilar; Product life-cycle management; Phase (matter); Competition (biology); Pharmaceutical industry; Marketing; Industrial organization; Computer science","score_opus":0.6685465453233798,"score_gpt":0.6240170960708625,"score_spread":0.04452944925251723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757851334","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18633483,0.0015241929,0.73055327,0.03213707,0.007212969,0.011722157,0.000037119695,0.0006828211,0.029795568],"genre_scores_gemma":[0.88095856,0.00034091854,0.1145002,0.00091349956,0.0025419325,0.00039449302,0.000016558603,0.000037528916,0.00029631404],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98516583,0.006679135,0.0039596995,0.0016915696,0.0017164792,0.0007872991],"domain_scores_gemma":[0.94415957,0.05059191,0.00074866135,0.0015487508,0.0013751991,0.0015759019],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20933482,0.00026845292,0.0012399752,0.0003471046,0.00028488337,0.00033688886,0.0011823832,0.00031073246,0.000013117044],"category_scores_gemma":[0.05554574,0.00021476793,0.00036431308,0.0014498176,0.0010399675,0.00032872436,0.0013379367,0.0010489676,0.00006464851],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081768486,0.00049214833,0.0001833543,0.000052404688,0.00017718913,0.000004893137,0.000028962997,0.00033535092,0.000013608586,0.55597323,0.014249363,0.42767182],"study_design_scores_gemma":[0.012924761,0.00094023556,0.010474428,0.00006753461,0.00009514438,0.0000040162454,0.00039468164,0.09402849,0.00021331292,0.7364598,0.14377439,0.0006232274],"about_ca_topic_score_codex":0.0000015512069,"about_ca_topic_score_gemma":6.832601e-7,"teacher_disagreement_score":0.6946237,"about_ca_system_score_codex":0.000072129485,"about_ca_system_score_gemma":0.0009019835,"threshold_uncertainty_score":0.9524098},"labels":[],"label_agreement":null},{"id":"W2759170843","doi":"10.2174/2213476x03666151221210747","title":"Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Biopharmaceutical; Medicine; Business; Risk analysis (engineering); Biotechnology","score_opus":0.7556914656993441,"score_gpt":0.5835080839316263,"score_spread":0.17218338176771775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759170843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47856858,0.44932655,0.00011571353,0.032126274,0.012489232,0.0052636093,0.00042120114,0.00033534892,0.021353513],"genre_scores_gemma":[0.8461861,0.14741132,0.0014849729,0.00086225633,0.0028138822,0.00007000288,0.000044713965,0.00007787873,0.0010488987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9820869,0.011090096,0.0042535164,0.0012162647,0.00049643725,0.00085677294],"domain_scores_gemma":[0.9804465,0.016225852,0.0008533311,0.0010361192,0.0006074911,0.0008307131],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.10423187,0.00041817158,0.002818804,0.00023745422,0.00025952814,0.000060966147,0.00051968417,0.0016742282,0.00028553206],"category_scores_gemma":[0.011100551,0.0002830826,0.00065460504,0.0003647961,0.007297339,0.000102958205,0.0008183306,0.002388492,0.000028347615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002923941,0.0011357665,0.004577055,0.0002872175,0.0007924234,0.000011411718,0.00010133055,1.3646975e-7,0.0007443383,0.083727084,0.080516234,0.82518303],"study_design_scores_gemma":[0.008624654,0.0019176063,0.025110522,0.00033122484,0.0004165037,0.000016757604,0.003349804,0.000015123297,0.0011720795,0.026797242,0.9316485,0.00059996446],"about_ca_topic_score_codex":0.000006341381,"about_ca_topic_score_gemma":0.0000068831423,"teacher_disagreement_score":0.8511323,"about_ca_system_score_codex":0.000035891604,"about_ca_system_score_gemma":0.000744536,"threshold_uncertainty_score":0.99996215},"labels":[],"label_agreement":null},{"id":"W2766000227","doi":"10.2174/2213476x03666160127001910","title":"Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Probiotic; Context (archaeology); Good manufacturing practice; Business; Quality (philosophy); Scopus; Product (mathematics); Risk analysis (engineering); Control (management); Marketing; MEDLINE; Computer science; Political science; Supply chain; Biology","score_opus":0.6378639548133486,"score_gpt":0.5791816973261519,"score_spread":0.05868225748719669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766000227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74282974,0.008337658,0.00186057,0.20342106,0.005427385,0.023366043,0.0011404944,0.0007005177,0.012916557],"genre_scores_gemma":[0.99310803,0.0013831253,0.0033558442,0.00034859747,0.0013604565,0.00018200636,0.00013455667,0.000007827189,0.00011954755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99160147,0.0037385116,0.0022477629,0.001080963,0.00062436593,0.00070693577],"domain_scores_gemma":[0.95416737,0.043250863,0.0005377124,0.00023183301,0.00053757825,0.001274646],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06178904,0.00028139917,0.0009949409,0.00005540324,0.00065289554,0.0002583168,0.00033002353,0.0004982798,0.000055196808],"category_scores_gemma":[0.024080591,0.00012966378,0.0003299573,0.0003038568,0.001155996,0.00017924812,0.00035011797,0.001275176,0.000017631282],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028323221,0.0022074361,0.0013374975,0.00007100452,0.00026030533,0.0000032033188,0.000062136096,0.000013392699,0.00075891236,0.022075754,0.010238637,0.9601394],"study_design_scores_gemma":[0.01132223,0.0043254066,0.028505389,0.00034090967,0.0005577109,0.000008608768,0.003501396,0.00441015,0.0011924983,0.03861034,0.90622103,0.0010043413],"about_ca_topic_score_codex":0.000008317077,"about_ca_topic_score_gemma":0.000025534584,"teacher_disagreement_score":0.95913506,"about_ca_system_score_codex":0.000061179184,"about_ca_system_score_gemma":0.0002203175,"threshold_uncertainty_score":0.98414},"labels":[],"label_agreement":null},{"id":"W2804493567","doi":"10.2174/2213476x03666151125220117","title":"Regulations of Cosmetics Across the Globe","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cosmetics; European union; Legislature; Business; Legislation; Political science; Medicine; Law; International trade","score_opus":0.543522808613697,"score_gpt":0.5977178971760421,"score_spread":0.05419508856234512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804493567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9040583,0.0033910475,0.0003532998,0.065741025,0.0015542451,0.002865593,0.000028534945,0.00016815103,0.021839814],"genre_scores_gemma":[0.99285555,0.0038355011,0.0008558234,0.00041494172,0.0009988266,0.0000339336,0.0000093021445,0.000026118785,0.0009700279],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913936,0.0030054674,0.0033300994,0.0006658193,0.001007973,0.00059701083],"domain_scores_gemma":[0.9736442,0.022828916,0.0006032657,0.0013591723,0.0007035447,0.0008609125],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.09945834,0.00019771537,0.001632019,0.0000890059,0.00031217805,0.000029461224,0.00039511907,0.0047943634,0.00004968801],"category_scores_gemma":[0.042130094,0.000108824046,0.0005659179,0.00064960157,0.0074366922,0.00003583011,0.00048004335,0.006379414,0.000054022454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014245981,0.0037860954,0.023259481,0.0002128667,0.002737228,0.00007636635,0.0012462205,0.000020647889,0.0008478694,0.4277765,0.14205569,0.38373506],"study_design_scores_gemma":[0.050339814,0.010040666,0.20697707,0.0007397954,0.0016976153,0.00014148116,0.03867611,0.001385961,0.0035747308,0.19812547,0.48719245,0.0011088252],"about_ca_topic_score_codex":0.0000065456893,"about_ca_topic_score_gemma":0.0000062883996,"teacher_disagreement_score":0.38262624,"about_ca_system_score_codex":0.000027146138,"about_ca_system_score_gemma":0.00059874204,"threshold_uncertainty_score":0.99649763},"labels":[],"label_agreement":null}]}